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A B S T R A C T
3-Ketosteroid Δ1-dehydrogenases are FAD-dependent enzymes that catalyze the introduction of a double bond
between the C1 and C2 atoms of the A-ring of 3-ketosteroid substrates. These enzymes are found in a large
variety of microorganisms, especially in bacteria belonging to the phylum Actinobacteria. They play a critical
role in the early steps of the degradation of the steroid core. 3-Ketosteroid Δ1-dehydrogenases are of particular
interest for the etiology of some infectious diseases, for the production of starting materials for the pharma-
ceutical industry, and for environmental bioremediation applications. Here we summarize and discuss the
biochemical and enzymological properties of these enzymes, their microbial sources, and their natural diversity.
The three-dimensional structure of a 3-ketosteroid Δ1-dehydrogenase in connection with the enzyme mechanism
is highlighted.
1. Introduction
Sterols are an abundant source of steroids in nature and a large
variety of microorganisms are able to transform them, either partially, or
completely to carbon dioxide and water. One such sterol is cholesterol (1
in Fig. 1). Its complex chemical structure requires the concerted action of
a large number of enzymes to completely degrade it. The occurrence of
genes coding for cholesterol-degrading enzymes in several bacterial and
fungal genome sequences [1], indicates that cholesterol degradation
pathways may be active in a variety of microorganisms.
A typical bacterial cholesterol degradation pathway is presented in
Fig. 1. Generally, the pathway is supposed to start with the oxidation or
dehydrogenation of cholesterol (1) to 5-cholesten-3-one (59; Fig. 2),
followed by isomerization to 4-cholesten-3-one (2). Under aerobic
conditions, this transformation is catalyzed by oxygen-dependent
bifunctional cholesterol oxidases/isomerases or 3β-hydroxysteroid de-
hydrogenases/isomerases [1–4], but under anaerobic conditions anoxic
bifunctional cholesterol dehydrogenase/isomerase enzymes take care of
the conversion [5,6]. Under aerobic conditions, the degradation of the
eight-carbon aliphatic side chain of cholesterol is initiated with the
hydroxylation of the C26 or C27 atom by the cytochrome P450
monooxygenase Cyp125 [7,8] or Cyp142 [9], followed by oxidation of
the hydroxyl group to a carboxylate by the same enzyme. The resulting
C26- or C27-carboxylate intermediate is subsequently activated as its
coenzyme A (CoA) derivative by an ATP-dependent steroid-CoA ligase
[10,11]. The release of the side chain has been elucidated biochemi-
cally to proceed through three cycles of a process similar to the β-oxi-
dation of fatty acids, yielding the nineteen-carbon steroid core inter-
mediate, e.g. 4-androstene-3,17-dione (AD; 8), by releasing successively
propionic acid, acetic acid, and another propionic acid [12,13]. Under
anaerobic conditions, bacteria use a similar route to degrade the side
chain [14]. However, the degradation is initiated by hydroxylation of 4-
cholesten-3-one (2) at C25, instead of at C26 or C27, to yield 25-hy-
droxy-4-cholesten-3-one (16), by an oxygen-independent hydroxylase
using a water molecule as the oxygen donor [5,6], and subsequent
isomerization to form 27-hydroxy-4-cholesten-3-one (3) [14]. The de-
gradation of the steroid nucleus is primed with the introduction of the
1(2)-double bond into the steroid ring system (see below). The 1(2)-
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unsaturated intermediate then follows either the 9,10-seco pathway for
aerobic degradation (magenta arrows in Fig. 1) or the 2,3-seco pathway
for anaerobic degradation (blue arrows in Fig. 1). More detailed in-
formation on microbial cholesterol degradation can be found elsewhere
[1–3].
Besides degrading cholesterol, the cholesterol degradation pathway
also offers a route to obtain useful starting materials for the production
of steroid drugs and hormones. Indeed, steroids are among the most
marketed pharmaceuticals with about 300 approved steroid drugs [15]
and a worldwide market of approximately 10 billion USD per year [16].
On the other hand, for some pathogenic microorganisms, the steroid
catabolic pathway is intimately involved in pathogenicity and viru-
lence. This is in particular the case for pathogenic bacteria such as
Mycobacterium tuberculosis and Rhodococcus equi, which depend on
cholesterol for survival inside macrophages [17,18]. Finally, the
pathway is important for clearance of steroid hormones released into
the aquatic environment by human activity, where they may affect the
physiology of aquatic organisms [19,20]. Thus, microbial steroid de-
gradation and conversion is of interest to multiple fields.
One of the important steroid-degrading enzymes is 3-ketosteroid Δ1-
dehydrogenase (3-oxosteroid 1-dehydrogenase; 4-ene-3-oxosteroid:
(acceptor)-1-ene-oxidoreductase; EC 1.3.99.4; Δ1-KSTD). In bacteria,
Fig. 1. Generalized scheme of bacterial cholesterol degradation. Cholesterol (1) is shown with the steroid ring nomenclature (A–D) and carbon numbering system
(1–27). The intermediates occurring in both aerobic and anaerobic degradation pathways are shown in black, while those found in aerobic or anaerobic pathways
only are in magenta or blue, respectively. The intermediates are (2) 4-cholesten-3-one; (3) 27-hydroxy-4-cholesten-3-one; (4) 3-oxo-4-cholesten-27-oic acid; (5) 3-
oxo-4-cholesten-27-oyl-CoA (3-OCS-CoA); (6) 3-oxo-4-cholen-24-oyl-CoA (3-OCO-CoA); (7) 3-oxo-4-pregnene-20-carboxyl-CoA (3-OPC-CoA); (8) 4-androstene-3,17-
dione (AD); (9) 1,4-androstadiene-3,17-dione (ADD); (10) 9α-hydroxy-1,4-androstadiene-3,17-dione (9-OHADD); (11) 3-hydroxy-9,10-seco-1,3,5(10)-androsta-
triene-9,17-dione (3-HSA); (12) 3,4-dihydroxy-9,10-seco-1,3,5(10)-androstatriene-9,17-dione (3,4-DHSA); (13) 4,5–9,10-diseco-3-hydroxy-5,9,17-trioxo-1(10),2-
androstadiene-4-oic acid (4,9-DSHA); (14) 9,17-dioxo-1,2,3,4,10,19-hexanorandrostan-5-oic acid (DOHNAA); (15) 2-hydroxy-2,4-hexadienoic acid (HHD); (16) 25-
hydroxy-4-cholesten-3-one; (17) 1-andro-stene-3,17-dione; (18) 1-hydroxyandrostane-3,17-dione; (19) androstane-1,13,17-trione; and (20) 1,17-dioxo-2,3-se-
coandrostan-3-oic acid (DSAO). Enzymes involved in the transformations are (A) cholesterol oxidase/isomerase or 3β-hydroxysteroid dehydrogenase/isomerase
[1–3]; (B) cytochrome P450 monooxygenases [7–9]; (C) steroid-CoA ligase [10,11]; (D) acyl-CoA dehydrogenase [13], enoyl-CoA hydratase, hydroxyacyl-CoA
dehydrogenase, thiolase [22]; (E) acyl-CoA dehydrogenase [23,24], enoyl-CoA hydratase [25], hydroxyacyl-CoA lyase; (F) 3-ketosteroid Δ1-dehydrogenase [26–30];
(G) 3-ketosteroid 9α-hydroxylase [31,32]; (H) non-enzymatic conversion; (I) 3-HSA 4-hydroxylase complex [33,34]; (J) 3,4-DHSA dioxygenase [17,35,36]; (K) 4,9-
DSHA hydrolase [17,37,38]; and (L, M, N, O, P, and Q) uncharacterized [5,6,14,39–41]. While the 1(2)-double bond is commonly introduced into the steroid core
after removal of the C17 side chain, in several microorganisms it may occur during the early steps of cholesterol degradation (dotted bonds).
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the enzyme is crucial for activating the steroid nucleus for degradation,
under both aerobic and anaerobic conditions, by catalyzing a 1(2)-de-
hydrogenation reaction. The enzyme is also important for the steroid
industry since it provides important starting materials for the produc-
tion of steroidal drugs and hormones. Moreover, Δ1-KSTD has been
validated in human macrophage cells as a good target for drug devel-
opment to combat M. tuberculosis and related organisms [21].
2. Δ1-KSTD and steroid degradation
2.1. Δ1-KSTD is essential for steroid ring opening under aerobic conditions
The introduction of a 1(2)-double bond into the steroid nucleus by
Δ1-KSTD constitutes an essential step in microbial steroid degradation.
Early research revealed that aerobic fermentation of AD (8) with a
Pseudomonas species led to the opening of the steroid B-ring yielding the
phenolic compound 3-HSA (11). This biotransformation appeared to
involve a 1(2)-dehydrogenation reaction (F in Fig. 1, presumably cat-
alyzed by a Δ1-KSTD) and a 9α-hydroxylation reaction (G, presumably
catalyzed by a 3-ketosteroid 9α-hydroxylase), followed by a sponta-
neous reverse-aldol type conversion (reaction H) [42]. Fermentation of
AD (8) with Nocardia A20-10 gave 3-HSA (11) and 9α-hydroxy-4-an-
drostene-3,17-dione (9-OHAD; 34) as products, confirming that 9α-
hydroxylation had taken place. Subsequent fermentation of the 9-
OHAD product with a 1(2)-dehydrogenating bacterium yielded 3-HSA,
confirming the 1(2)-dehydrogenation [43,44]. It was postulated that
the 9-OHAD conversion proceeded via the unstable 9-OHADD (10) to
yield 3-HSA [42,45]. A similar conversion, i.e. 1(2)-dehydrogenation
followed by a spontaneous reverse-aldol reaction, was observed in the
A-ring aromatization of 4-androsten-19-ol-3,17-dione (38) to estrone
(39) during fermentation with the Pseudomonas species mentioned
above [45] and Moraxella sp. [46]. These results suggest that the Δ1-
KSTD and 3-ketosteroid 9α-hydroxylase activities prime the steroid
nucleus of Δ4-3-ketosteroids for aerobic degradation via the 9,10-seco
pathway (magenta arrows in Fig. 1) by opening the B ring.
AD (8) is a common substrate of Δ1-KSTDs [27–29,47–53], in-
dicating that cholesterol side-chain degradation may precede steroid
nucleus opening. This was particularly observed in M. fortuitum NRRL
B-8153 [54], R. jostii RHA1 [8], and M. bovis BCG [7]. However, in
other microorganisms, such as R. equi (synonym Nocardia restrictus)
ATCC 14887 [12,55] andM. tuberculosis H37Rv [56], the side chain and
nucleus degradations apparently occur simultaneously and in-
dependently. In these cases, the 1(2)-double bond is introduced in
cholesterol degradation intermediates earlier than AD. For instance, the
3-ketosteroid 9α-hydroxylase from M. tuberculosis H37Rv has a higher
specificity constant toward 3-oxo-23,24-bisnor-chola-1,4-dien-22-oic
acid (3-oxo-1,4-pregnediene-20-carboxyl-CoA; cf. 7) than ADD (9) [56],
suggesting that 1(2)-dehydrogenation has taken place at 7 or earlier
intermediates. Similarly, the Δ1-KSTD from Sterolibacterium denitrificans
Chol-1ST prefers 4-cholesten-3-one (2) over AD as its substrate [47].
Thus, 1(2)-dehydrogenation by Δ1-KSTDs may also occur during the
early steps of cholesterol degradation (dotted bonds in Fig. 1).
Fig. 2. Selected steroid structures discussed in this review. See main text for the steroid names.
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2.2. Importance of Δ1-KSTDs
Since these first results, Δ1-KSTD activity has been identified in
many other microorganisms, albeit sometimes with different substrate
preferences. For instance, Comamonas testosteroni ATCC 11996 (for-
merly Pseudomonas testosteroni) is active on several steroid substrates,
but it cannot use 11β-hydroxy and 11-keto steroids such as cortisol (48)
and cortisone (53), because its Δ1-KSTD is not active toward these
substrates [50]. Similarly, R. equi can completely degrade progesterone
(43), but degradation of A-nor-testosterone (21) halts at 9α-hydroxy-A-
nor-4-androstene-3,17-dione (33), since its Δ1-KSTD cannot oxidize the
5-membered A ring of this substrate [57]. Evidence for the essentiality
of Δ1-KSTD comes from Δ1-KSTD-defective bacterial strains, such as M.
fortuitum NRRL B-8119 [58], M. roseum sp. nov. 1108/1 [59], and
Mycobacterium sp. VKM Ac1817D [107]. These strains degrade their
steroid substrates only up to the Δ1-KSTD substrate 9-OHAD (34).
Likewise, inactivation of tesH, the Δ1-KSTD gene in C. testosteroni
TA441, destroyed its capability to grow on testosterone and resulted in
accumulation of AD (8) and 9-OHAD [26]. More recently, it was shown
that disruption of the Δ1-KSTD gene of M. tuberculosis H37Rv gave rise
to growth attenuation and 9-OHAD accumulation with cholesterol as
sole carbon source [60,61]. Finally, the importance of Δ1-KSTD in mi-
crobial steroid degradation is also reflected by the frequent presence of
multiple Δ1-KSTD genes in steroid-degrading microorganisms. In-
activation of two out of three Δ1-KSTD genes in R. erythropolis SQ1 still
allowed the resulting mutant to grow on cholesterol without accumu-
lation of any steroid intermediates [28]. On the other hand, disruption
of all identified Δ1-KSTD genes in M. neoaurum ATCC 25795 resulted in
a mutant that is still able to degrade cholesterol, but only up to 9-OHAD
[62]. Interestingly, while R. ruber Chol-4 harbors three genes for Δ1-
KSTDs, i.e. kstD1, kstD2, and kstD3, a double-gene deletion of kstD2 and
kstD3 was sufficient to completely abolish its capability to grow in
minimal medium with cholesterol (1) as the only carbon source [63].
Together, these observations strongly support that Δ1-KSTDs are es-
sential enzymes for microbial steroid degradation.
2.3. Sequence of early steps in steroid ring opening under aerobic conditions
Depending on the organism, the 1(2)-dehydrogenation and 9α-hy-
droxylation of AD (8) to yield the unstable intermediate 9-OHADD (10)
can occur sequentially, i.e. 1(2)-dehydrogenation followed by 9α-hy-
droxylation or the other way round, or simultaneously. In the in-
complete ring-A aromatization of AD with a species of Pseudomonas
studied by Dodson and Muir [42] ADD (9) was one of the products,
implying that the bacterium first 1(2)-dehydrogenates AD to ADD and
subsequently hydroxylates ADD at C-9 to 9-OHADD. The same sequence
of events was suggested for the conversion of AD with R. ruber strain
Chol-4, as ADD was detected as main intermediate in the course of the
fermentation [63]. Likewise, M. tuberculosis H37Rv most likely uses the
same route to open the steroid B-ring, since its 3-ketosteroid 9α-hy-
droxylase enzyme displayed a clear preference for ADD over AD [31].
On the other hand, the opposite sequence was suggested for ar-
omatization-degradation of AD with a species of Nocardia A20-10. As
stated above, from a fermentation of AD using this bacterium, 9-OHAD
was isolated from the mixture with 3-HSA (11), indicating that 9α-
hydroxylation followed by 1(2)-dehydrogenation took place [43].
Furthermore, with R. erythropolis SQ1 1(2)-dehydrogenation and 9α-
hydroxylation were proposed to occur simultaneously in the conversion
of AD to 9-OHADD with a preference for 9α-hydroxylation followed by
1(2)-dehydrogenation to keep a low intracellular ADD concentration
[64]. Two Δ1-KSTD isoenzymes of strain SQ1 involved in this conver-
sion showed comparable affinities (KM values) for AD and 9-OHAD
[28], but a high ADD concentration was moderately toxic to the bac-
terium [64,65]. Thus, a microbial species may use one of the above-
mentioned three available routes to convert AD to 9-OHADD. However,
the possibility of the species to switch from one route to another,
depending on which 3-ketosteroid(s) are available, may apply as well.
2.4. Δ1-KSTD is also essential for steroid ring opening under anaerobic
conditions
1(2)-Dehydrogenation by a Δ1-KSTD is also a crucial step during
anaerobic degradation of the steroid core. Several Δ1-KSTDs were
shown to be active under either aerobic or anaerobic conditions
[27,29,47,50,66]. Furthermore, the last common intermediate of both
aerobic and anaerobic steroid degradation pathways appeared to be the
product of Δ1-KSTD activity [14,39,40], i.e. a Δ1-3-ketosteroid. In an
anaerobic environment, the C1-C2 double bond of a Δ1-3-ketosteroid is
hydrated to result in the corresponding C1-hydroxylated intermediate,
which then follows the 2,3-seco pathway to degrade its steroid core
(blue arrows in Fig. 1) [14,39–41]. Altogether, Δ1-KSTD is essential for
microbial steroid degradation. It is required for opening the steroid
nucleus under both aerobic and anaerobic conditions.
3. Microbial sources of Δ1-KSTD
3.1. Occurrence of Δ1-KSTD activity in microorganisms
Microbial steroid 1(2)-dehydrogenation was first reported for the
fungi Fusarium solani and F. caucasicum, which converted Δ4-pregnene-
3,20-diones, AD (8), and Δ5-3β-hydroxy steroids into ADD (9) [67].
Similar transformations were demonstrated for the bacterium Strepto-
myces lavendulae and the fungus Cylindrocarpon radicicola ATCC 11011,
which fermented progesterone (43) into ADD and 1-dehy-
drotestololactone (40), respectively [68]. Since then, such bio-
transformations on various steroid substrates have been reported for a
large number of fungi and bacteria. Some recent examples of such
microorganisms are M. neoaurum DSM 1381 [69], R. ruber Chol-4 [70],
and Gordonia neofelifaecis NRRL B-59395 [71]. Indeed, a search in the
NCBI protein database revealed that putative Δ1-KSTD enzymes are
present in almost 500 different microbial species. The large number and
variety of microorganisms that may express this enzyme attest to its
physiological role and importance.
3.2. Δ1-KSTD isoenzymes
It has been found that several microorganisms are able to express
multiple Δ1-KSTD isoenzymes (Supplementary Table S1). M. fortuitum
ATCC 6842 was reported to produce two different Δ1-KSTDs, depending
on the steroid inducers applied. When induced with AD (8) a mem-
brane-associated Δ1-KSTD, which was more active toward AD than to-
ward 9-OHAD (34), was upregulated. In contrast, when induced with
9α-hydroxyprogesterone (44) the bacterium expressed a soluble Δ1-
KSTD with a higher activity on 9-OHAD than on AD [53]. In R. ery-
thropolis SQ1, three Δ1-KSTD isoenzymes have been found, i.e. Δ1-
KSTD1 [72], Δ1-KSTD2 [65,73], and Δ1-KSTD3 [28], with different
substrate specificities. While Δ1-KSTD1 and Δ1-KSTD2 displayed a
broad 3-ketosteroid substrate range with the best activity on 9-OHAD
and AD, respectively, Δ1-KSTD3 had a high preference for 5α-andros-
tane-3,17-dione (31) and 5α-testosterone (23) [28]. In M. smegmatis
mc2155 two genes, ksdD1 and ksdD2, encode Δ1-KSTD enzymes. Tar-
geted disruption of ksdD1 partially inactivated the cholesterol de-
gradation pathway by this bacterium, leading to the accumulation of
the intermediate AD. On the other hand, inactivation of ksdD2 did not
affect the degradation pathway. Nevertheless, the enzyme expressed by
this latter gene did exhibit Δ1-KSTD activity, albeit low, during myco-
bacterial growth on cholesterol [74]. Similarly, R. ruber Chol-4 contains
three gene copies for Δ1-KSTD, i.e. kstD1, kstD2, and kstD3. While the
role of KstD1 remains unclear, the enzymes encoded by kstD2 and kstD3
were verified to be involved in cholesterol utilization by the bacterium.
Specifically, KstD2 was important for 1(2)-dehydrogenation of AD and
9-OHAD [63]. More recently, M. neoaurum ATCC 25795 was found to
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express three Δ1-KSTD isoenzymes, i.e. MN-KstD1 (GenPept
ACV13200.1), MN-KstD2 (GenPept AHG53938.1), and MN-KstD3
(GenPept AHG53939.1), with distinct transcriptional responses to
steroids. The isoenzymes were able to 1(2)-dehydrogenate AD, 9-OHAD
and testosterone (24) but with some significant differences in their
substrate preferences. In particular, MN-KstD1 and MN-KstD2 were also
active toward 5α-testosterone (23) [62]. The NCBI protein database
contains many other species with two or more putative Δ1-KSTD se-
quences, such as the actinobacterium R. opacus PD630 (GenPepts
AHK28217.1, AHK29640.1, AHK29660.1, AHK33894.1, AHK34331.1)
and the fungus Aspergillus fumigatus Af293 (GenPepts XP_751348 and
XP_753296). Thus, it appears that steroid-degrading microorganisms
may use multiple Δ1-KSTDs to 1(2)-dehydrogenate steroids, most
probably as a strategy to increase their capability in degrading various
steroid substrates.
4. Diversity of Δ1-KSTD
4.1. Phylogenetic analysis
Δ1-KSTDs have rather diverse amino acid sequences. A sequence
distance analysis using the program MEGA6 [75] of all currently bio-
chemically characterized Δ1-KSTDs yielded a largest p-distance [76] of
0.67 (on a scale of 0–1) for the Δ1-KSTDs from the actinobacteria No-
cardioides simplex IFO 12069 (GenPept BAA07186.1; also called Pime-
lobacter simplex, Arthrobacter simplex, or Corynebacterium simplex) [77]
and M. neoaurum ATCC 25795 (GenPept AHG53938.1) [62] with an
amino acid identity of 30%. When all currently available putative Δ1-
KSTD sequences are included in the analysis, a p-distance as large as
0.72 was found for the Δ1-KSTDs from the actinobacterium Aero-
microbium marinum (GenPept WP_007078704.1) and the proteo-
bacterium Vitreoscilla stercoraria (GenPept WP_040755675.1), which
have a sequence identity of 26% only.
A phylogenetic analysis of Δ1-KSTD sequences resulted in a clado-
gram with several different clades, i.e. clades A, B, C, and D (Fig. 3). All
Δ1-KSTDs from fungi of the phylum Ascomycota and bacteria of the
phylum Chloroflexi are clustered in subclade A1, which also includes an
archaeal Δ1-KSTD from Candidatus Caldiarchaeum subterraneum. Sub-
clade A2 contains actinobacterial Δ1-KSTDs in one cluster and proteo-
bacterial enzymes in the other cluster. Subclade B1 mostly contains Δ1-
KSTDs from Firmicutes bacteria and the amoebozoa P. pallidum PN500.
Subclade B2 is mostly occupied by actinobacterial enzymes, but it also
comprises a Δ1-KSTD from the bacterium Empedobacter falsenii, a
member of the phylum Bacteroidetes. Although Δ1-KSTDs from Acti-
nobacteria can be found in virtually all clades, the majority of these
enzymes are in subclade B2 and in clade C. Similarly, the enzymes from
Proteobacteria are present in several clades, but mainly clustered in
clade D. This latter clade also accommodates some actinobacterial Δ1-
KSTDs. Hence, in general, Δ1-KSTDs are phylogenetically clustered on
the basis of their microbial sources.
4.2. The phylogenetic tree and substrate specificity
The phylogenetic analysis placed Δ1-KSTDs with similar substrate
specificities in the same clade. For instance, Δ1-KSTD3 from R. ery-
thropolis SQ1 (GenPept ABW74859.1) and Δ1-KSTD from M. tuberculosis
H37Rv (GenPept NP_218054.1), which are both active on 5α-3-ketos-
teroids, but not on Δ4-3-ketosteroids [28], are both in subclade B2. The
subclade B2 Δ1-KSTD from M. neoaurum ATCC 25795 (GenPept
ACV13200.1) is also active on 5α-3-ketosteroids (5α-testosterone (23)),
although this enzyme has a more relaxed substrate specificity, and can
also convert Δ4-3-ketosteroid substrates [62]. In contrast, the clade C
Δ1-KSTD1 of R. erythropolis SQ1 (GenPept AAF19054.1) is active on Δ4-
3-ketosteroids, while the subclade B2 Δ1-KSTD3 of the same bacterial
(caption on next page)
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strain (GenPept ABW74859.1) prefers 5α-3-ketosteroids [28]. Three Δ1-
KSTD isoenzymes fromM. neoaurum ATCC 25,795, assigned to subclade
B1 (GenPept AHG53938.1), subclade B2 (GenPept ACV13200.1), and
clade C (GenPept AHG53939.1), were also reported to display sig-
nificant differences in substrate preference [62]. Thus, these observa-
tions suggest that Δ1-KSTDs residing in the same clade have similar
substrate specificities, which may differ from the substrate specificities
of Δ1-KSTDs from other clades.
4.3. Distribution of isoenzymes in the phylogenetic tree
In the cladogram, multiple Δ1-KSTD isoenzymes of a particular or-
ganism tend to be distributed across several clades, instead of clustered
in a single clade. For instance, the five Δ1-KSTD isoenzymes from the
actinobacterium R. opacus PD630 appear in clades B (subclades B1 and
B2), C, and D. Similarly, the Δ1-KSTD isoenzymes from the actino-
bacteria R. erythropolis, N. simplex, and M. neoaurum, as well as the
proteobacterium Novosphingobium malaysiense are found in several dif-
ferent clades. If the presence in different clades is correlated with dif-
ferences in substrate specificity, as suggested above, these distributions
may reflect the capability of the corresponding microorganisms to use a
diverse variety of steroid substrates.
5. Steroid inducibility of Δ1-KSTD
Enzymes involved in microbial steroid degradation are generally not
expressed constitutively, but they are upregulated depending on which
steroid substrates are present [17,81]. Thus, a cell-free extract prepared
from testosterone-adapted C. testosteroni ATCC 11996 cells displayed a
1(2)-dehydrogenation specific activity that was about 50 times higher
than that of a cell-free extract prepared from unadapted cells [50]. In
addition, such induction is species specific. Although testosterone (24)
was a good Δ1-KSTD inducer for C. testosteroni ATCC 11996, it had a
poor effect on R. equi. The best tested inducer for this latter bacterium
was progesterone (43), which increased the 1(2)-dehydrogenation
specific activity about 8-fold compared to steroid-uninduced cells [29].
Furthermore, the induction is also steroid specific. Particular steroids,
e.g. cortisol (48), were 1(2)-dehydrogenated slowly by Septomyxa affinis
and, therefore, were termed "slow" steroids. Indeed, the dehydrogena-
tion could be accelerated by adding a small quantity of a second steroid
as stronger inducer, such as progesterone, AD (8), 3-oxo-23,24-bisnor-
4-cholen-22-ol (54), 3-oxo-23,24-bisnor-4-cholen-22-al (55), or 3-oxo-
23,24-bisnor-4-cholen-22-oic acid (56) [82]. Similar inductions were
also reported for Δ1-KSTD expression in many other microorganisms,
such as R. erythropolis (formerly Nocardia erythropolis) IMET 7185 [83],
R. erythropolis (formerly Nocardia opaca and R. rhodochrous) IMET 7030
[84], and Bacillus cereus [85]. However, there may also be growth stage
differences: for instance, in the spores of F. solani a Δ1-KSTD is ex-
pressed constitutively, but in the mycelium state of the fungus it is
induced [86].
6. Nature and properties of Δ1-KSTD
6.1. Electron acceptor
Removal of cellular debris from Δ1-KSTD-containing cell extracts
resulted in the loss of almost all 1(2)-dehydrogenating activity
[27,47,66,87]. However, the activity could be restored by adding ex-
ternal electron acceptors such as phenazine methosulfate, menadione,
2,6-dichlorophenol-indophenol, resazurin, Wurster's blue, methylene
blue, coenzyme Qs, or vitamin Ks [27,29,47,50,66,87–91]. Molecular
oxygen has also been reported to act as an external electron acceptor for
Δ1-KSTDs from Clostridium paraputrificum [92], R. rhodochrous (for-
merly Nocardia corallina) IFO 3338 [27], and R. erythropolis SQ1 iso-
enzyme 3 [28]. On the other hand, a number of other electron acceptors
were not compatible, including FAD, FMN, DPN, TPN, NAD+, NADP+,
cytochrome c, and coenzyme Q10 [27,29,47,50,66,91]. While ferri-
cyanide was generally reported not to be a good electron acceptor for
the activity of Δ1-KSTDs, it was active with the enzyme from the de-
nitrifying Gram-negative bacterium S. denitrificans Chol-1ST [47].
6.2. The nature and role of the prosthetic group
As mentioned above, Δ1-KSTDs can utilize either phenazine meth-
osulfate or 2,6-dichlorophenol-indophenol as the external electron ac-
ceptor. Moreover, the enzyme is strongly inhibited by acriflavin
[29,50]. Since these properties have also been observed for various
flavoproteins, it was proposed already early on that Δ1-KSTDs might use
flavin as a prosthetic group for their dehydrogenating activity [29,50].
This hypothesis was supported by the bright yellow colour of purified
Δ1-KSTDs that exhibited absorption maxima around 270, 370, and
460 nm, which are typical for flavoproteins [27,30,47,48,93]. Final
proof of the nature of the prosthetic group was obtained from recon-
stitution experiments with purified apo-Δ1-KSTD. Only when FAD was
added to the apo-enzyme, the activity was fully restored, thus identi-
fying FAD as the prosthetic group of Δ1-KSTD [27,94]. Crystal struc-
tures of R. erythropolis SQ1 Δ1-KSTD1 showed that one FAD is bound per
enzyme molecule through non-covalent interactions only, including
hydrogen bonds, van der Waals contacts, and dipole-dipole interactions
[30]. Nevertheless, the binding is tight, with a dissociation constant of
0.075 μM for the Δ1-KSTD from R. erythropolis IMET 7030 [94], and
4.7 μM for the Δ1-KSTD from R. rhodochrous IFO 3338 [27]. The role of
the prosthetic group during steroid 1(2)-dehydrogenation is essential;
presumably it accepts the axial α-hydrogen (see Fig. 4) from the C1
atom of the steroid substrate as a hydride ion [95–98]. Indeed, this
hypothesis was confirmed by the crystal structure of the Δ1-KSTD1•ADD
complex, in which the N5 atom of the isoalloxazine ring of the FAD
prosthetic group is positioned at the α-side of ADD, at reaction distance
to the C1 atom of the steroid, suitable to accept a hydride ion from the
C1 atom [30].
6.3. Cellular location of Δ1-KSTDs
Δ1-KSTDs are generally reported to be intracellular enzymes, either
soluble or bound to subcellular particles. For instance, the enzymes
from C. testosteroni ATCC 11996 and ATCC 17410 [50,90,99], R. equi
[29], and N. simplex ATCC 6946 [52] were particulate-bound. On the
other hand, the Δ1-KSTDs from B. sphaericus ATCC 7055 [66], R. rho-
dochrous IFO 3338 [27], S. denitrificans Chol-1ST [47] and A. fumigatus
CICC 40,167 [100] were considered to be soluble. However, several
bacteria, including N. simplex VKM Ac-2033D (formerly Arthrobacter
globiformis 193) [101,102], R. erythropolis IMET 7030 [84,103–106],
Fig. 3. Unrooted phylogenetic analysis of Δ1-KSTDs. Δ1-KSTD protein se-
quences were obtained from the NCBI protein database using all variants of the
enzyme name as queries. To prepare a non-redundant size-reduced dataset, the
sequences with more than 60% identity were clustered using the program CD-
HIT [78]. The cluster-representing sequences were aligned to the amino acid
sequence of the structurally characterized Δ1-KSTD1 from Rhodococcus ery-
thropolis SQ1 [30] using ClustalW2 [79] and visually inspected for the details of
their alignment; the sequences that are incomplete and/or do not conserve the
key amino acid residues, i.e. the residues that correspond to Tyr-119, Tyr-318,
Tyr-487, and Gly-491 of Δ1-KSTD1, were removed from the dataset. All bio-
chemically characterized Δ1-KSTD sequences (*) were then included into the
dataset. Likewise, multiple Δ1-KSTD isoenzyme sequences from several species
(bold) were also added. The sequences in the resulting dataset were multiply-
aligned with ClustalW2 and the cladogram was obtained from this alignment
using the Neighbor-Joining method [80] implemented in the program MEGA6
[75]. The taxa identifications are: phylum|species–the NCBI protein data-base
accession number; the phyla Act, Asc, Bac, Chl, Fir, Myc, Pro, and Tha stand for
Actinobacteria, Ascomycota, Bacteroidetes, Chloroflexi, Firmicutes, Mycetozoa,
Proteobacteria, and Thaumarchaeota, respectively.
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and Mycobacterium sp. VKM Ac1817D [107], were shown to produce
both soluble and particulate-bound Δ1-KSTDs. This property is likely to
be protein-dependent rather than species-dependent, but it may also
depend on the particular substrate to be converted, as for instance
shown by M. fortuitum ATCC 6842, which produced a cytoplasmic
membrane-bound Δ1-KSTD when induced with AD (8), but a soluble
isoenzyme when induced with 9α-hydroxyprogesterone (44) [53].
Surprisingly, extracellular Δ1-KSTD activities were found in the fer-
mentation broths of M. neoaurum (formerly Mycobacterium sp. and M.
vaccae) VKM Ac-1815D [108] and Mycobacterium sp. VKM Ac1817D
[107]. However, the extracellular Δ1-KSTD from M. neoaurum VKM Ac-
1815D was associated with a 3β-hydroxysteroid oxidase secreted by the
cells [108], which may have triggered the secretion of the Δ1-KSTD.
Thus, it appears that Δ1-KSTD activities are localized mostly inside the
cell, which makes sense in view of the requirement of reducing the
prosthetic group after the reaction.
6.4. Molecular mass of Δ1-KSTDs
The experimentally determined molecular masses of Δ1-KSTDs are
around 53–61 kDa [27,28,47,48,62,90,93,100,105,109]. The Δ1-KSTDs
from R. rhodochrous IFO 3338 [27], N. simplex IFO 12069 [48], and R.
erythropolis SQ1 isoenzyme 1 [30] are monomeric proteins, whereas the
enzyme from S. denitrificans Chol-1ST [47] forms soluble oligomeric
aggregates. Uniquely, the Δ1-KSTD from Mycobacterium sp. VKM Ac-
1817D with a molecular mass of ˜58 kDa was proposed to be a dimer
consisting of 34 and 23 kDa protein subunits [107].
6.5. Isoelectric point of Δ1-KSTDs
Δ1-KSTDs from R. rhodochrous IFO 3338 [27] and R. erythropolis
IMET 7030 [84,93,105] were identified as acidic proteins with iso-
electric point (pI) values of 3.1 and 4.7, respectively. However, pI
calculations using the ProtParam tool (http://web.expasy.org/
compute_pi/) suggest that the pIs of (putative) Δ1-KSTDs currently
available in GenPept vary considerably, ranging from 4.5 (R. qingshengii
BKS 20–40; GenPept EME18626) to 9.6 (Cupriavidus necator; GenPept
WP_042876660).
6.6. Optimum pH of Δ1-KSTD activity
The characterized Δ1-KSTDs generally show optimum activity at
basic conditions (pH 8.0–10.0) [27,29,48–50,92,110]. Indeed, Δ1-
KSTD1 from R. erythropolis SQ1 is most stable at pH 9.0 [111]. Since Δ1-
KSTDs employ a catalytic base to abstract a proton from its substrate
[30,96–98], the basic environment may strengthen the basic character
of the catalytic base. In contrast, the enzyme from S. denitrificans Chol-
1ST was reported to have its maximum activity at pH 6.0 [47]. Thus,
like the pI, the optimum pH for activity of Δ1-KSTDs appears to vary
quite significantly among the enzymes.
7. Substrates of Δ1-KSTD
AD (8), a central microbial cholesterol degradation intermediate
after removal of the C-17 side chain, is a common substrate of Δ1-
KSTDs. Almost all characterized Δ1-KSTDs effectively catalyze 1(2)-
dehydrogenation of this 3-ketosteroid [27–29,47–53]. In addition, Δ1-
KSTDs are also able to 1(2)-dehydrogenate a wide range of other steroid
substrates with varying activity.
7.1. Substituents at the C3 position
The presence of a keto group at the C3 position of the steroid sub-
strates is crucial for catalysis by Δ1-KSTDs. Δ1-KSTD from C. testosteroni
ATCC 11996 was found to 1(2)-dehydrogenate various 3-ketosteroids
such as 19-nor-4-androstene-3,17-dione (28), cortexolone (47), and
progesterone (43), but not 3-hydroxysteroids, including 3α-hydroxy-
5α-androstan-17-one (29) and 3β-hydroxy-5α-androstan-17-one (30)
[50]. Similar observations have been reported for the Δ1-KSTDs from R.
equi [29], N. simplex ATCC 6946 and IFO 12069 [48,49,51,52], Clos-
tridium paraputrificum [92], M. fortuitum ATCC 6842 [53], R. rhodo-
chrous IFO 3338 [27], R. erythropolis SQ1 [28], S. denitrificans Chol-1ST
[47], and M. neoaurum ATCC 25795 [62]. The Δ1-KSTD from S. deni-
trificans Chol-1ST was also inactive on steroids lacking a functional
group at the C3 position such as 5α-cholestane (58) [47]. On the basis
of these observations the steroid C3 keto group was proposed to interact
with an electrophilic or proton donating residue(s) of the enzyme to
promote keto-enol tautomerization and labilization of the C2 hydrogen
atoms [30,95–98]. Indeed, in the crystal structure of the Δ1-
KSTD1•ADD complex [30], the steroid C3 keto group was observed at
hydrogen bonding distance from the hydroxyl group of Tyr-487 and the
backbone amide of Gly-491 (Fig. 4), two amino acid residues that are
absolutely conserved among Δ1-KSTDs (Supplementary Figure S2).
7.2. Effect of a C4-C5 double bond
The presence of a double bond at the substrate’s C4-C5 position
affects the reactivity of Δ1-KSTDs to varying extent, depending on the
enzyme. Most 3-ketosteroids that are converted by Δ1- KSTDs have this
double bond. For some Δ1-KSTDs this double bond is even required,
such as the Δ1-KSTD from N. simplex ATCC 6946 and IFO 12069, which
had no activity on 5α- (31) and 5β-androstane-3,17-dione (32)
Fig. 4. Mechanism of 3-ketosteroid dehydrogenation as catalyzed by Δ1-KSTD1 [30]. The stereo nomenclature of steroids is shown in inset (A) and the stereo-
heterotopic faces of the flavin ring system are shown in inset (B). Dashed lines represent hydrogen bonds. See text for explanation.
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[48,51,52]. Similarly, both Δ1-KSTDs from wild-typeM. fortuitum ATCC
6842 were able to 1(2)-dehydrogenate 9-OHAD (34), while they were
inactive on 9α-hydroxy-5-androstene-3,17-dione (35) [53]. On the
other hand, the double bond was not necessary for the activity of a Δ1-
KSTD from B. sphaericus ATCC 7055 since this enzyme 1(2)-dehy-
drogenated 5α-androstane-3,17-dione (31) and AD (8) with identical
Vmax values [97]. Likewise, a Δ1-KSTD from S. denitrificans Chol-1ST
was active on 5-cholesten-3-one (59) with the same catalytic efficiency
(kcat/KM) as on 4-cholesten-3-one (2) [47]. Δ1-KSTD3 from R. ery-
thropolis SQ1 and a Δ1-KSTD from M. tuberculosis H37Rv even preferred
5α-3-ketosteroids with a saturated A-ring such as 5α-androstane-3,17-
dione (31), 5α-testosterone (23), and 5α-pregnane-3,20-dione (42).
Intriguingly, these enzymes were seemingly inactive on AD (8) and
several other Δ4-3-ketosteroids [28]. Similarly, a Δ1-KSTD from the
intestinal bacterium Clostridium paraputrificum was not able to 1(2)-
dehydrogenate AD, but, in contrast to the former two enzymes, it was
only active on 5β-3-ketosteroids like 5β-androstane-3,17-dione (32)
and 3-oxo-5β-cholan-24-oic acid (57) [92]. Thus, these data show that
Δ1-KSTDs may differ considerably in their requirement for the presence
of a double bond at the C4-C5 position of the steroid substrate.
7.3. Substituents at the C9 position
Δ1-KSTDs respond also differently to 9α-substituted 3-ketosteroids.
A Δ1-KSTD from R. equi 1(2)-dehydrogenated 9α-fluorocortisol (50)
and 9α-fluoro-16α-hydroxycortisol (51) with comparable activities as
cortisol (48), which has no substituent at C9 [29]. Similarly, a Δ1-KSTD
from N. simplex ATCC 6946 was not inhibited by the presence of a
fluorine substituent at the 9α position [52]. 9-OHAD (34), a key in-
termediate of microbial cholesterol degradation, which contains a hy-
droxyl group at C9, was converted by Δ1-KSTD1 and Δ1-KSTD2 from R.
erythropolis SQ1 [28], as well as by all Δ1-KSTDs from M. fortuitum
ATCC 6842 [53] and M. neoaurum ATCC 25795 [62]. In contrast, this
steroid was not converted by Δ1-KSTD3 from R. erythropolis SQ1 and a
Δ1-KSTD from M. tuberculosis H37Rv [28]. Thus, while it appears that
Δ1-KSTD1s can accept a small fluorine substituent at C9, a larger hy-
droxyl group cannot be accommodated by all enzymes.
7.4. Substituents at the C10 position
A methyl group at the 10β position of 3-ketosteroid substrates is not
essential for Δ1-KSTD function. The Δ1-KSTDs from C. testosteroni ATCC
11996 [50], R. equi [29], N. simplex ATCC 6946 and IFO 12069
[48,49,52], and S. denitrificans Chol-1ST [47] all catalyzed 1(2)-dehy-
drogenation of 19-nor-testosterone (22). Moreover, Δ1-KSTD from R.
rhodochrous IFO 3338 [27] was active on 19-nor-4-androstene-3,17-
dione (28). Yet, these steroids were 1(2)-dehydrogenated less rapidly
by the enzymes than their 10β-methyl counterparts [27,29,47,48,50].
The 10β-methyl group is possibly recognized by the enzyme, since in
the crystal structure of Δ1-KSTD1•ADD (Protein Data Bank code 4c3y
[30]) the 10β-methyl group is at van der Waals distance to the Phe-116,
Phe-294, Tyr-318, and Ile-354 side chains. Interestingly, a Δ1-KSTD
from Moraxella sp. was able to 1(2)-dehydrogenate a substrate with a
hydroxymethyl group at the 10β position, i.e. 4-androsten-19-ol-3,17-
dione (38) [46] and a Δ1-KSTD from N. simplex ATCC 6946 was re-
ported to be active on 3-ketosteroids with an ethyl group at the 10β or
13β positions, but not with larger substituents at these positions [51].
Indeed, inspecting the Δ1-KSTD1•ADD structure, enough space appears
to be present in the active site of the enzyme to accommodate ethyl, but
not larger substituents at the 10β or 13β positions.
7.5. Substituents at the C11 position
An oxygen-containing substituent at the C11 position also affects
the catalytic activity of Δ1-KSTDs. The Δ1-KSTDs from the Gram-posi-
tive bacteria R. equi [29], N. simplex ATCC 6946 and IFO 12069
[48,49,52], and R. rhodochrous IFO 3338 [27] were able to 1(2)-de-
hydrogenate 11α-hydroxy-, 11β-hydroxy-, or 11-keto-3-ketosteroids,
e.g. 11α-hydroxyprogesterone (45), 11β-hydroxy-4-ansdrostene-3,17-
dione (36), adrenosterone (37), cortisol (48), cortisone (53) or corti-
costerone (46). Likewise, Δ1-KSTD1 and Δ1-KSTD2 from R. erythropolis
SQ1 were active on cortisol [28]. On the other hand, Δ1-KSTDs from the
Gram-negative bacteria C. testosteroni ATCC 11996 [50] and S. deni-
trificans Chol-1ST [47] were inactive on both 11β-hydroxy- and 11-keto-
3-ketosteroids, although the Δ1-KSTD from C. testosteroni ATCC 11996
could 1(2)-dehydrogenate 11α-hydroxytestosterone (25) [50]. In gen-
eral, 3-ketosteroids oxygenated at C11 are less easily converted by Δ1-
KSTDs than their non-oxygenated analogs [27,29,50]. Yet, the Δ1-KSTD
from R. equi catalyzed the 1(2)-dehydrogenation of 11α-hydroxy-pro-
gesterone (45) at a similar rate as progesterone (43) [29] and cortisone
(53) was a good substrate for the Δ1-KSTD from R. rhodochrous IFO
3338 [27]. Thus, an oxygen-containing substituent at the C11 position
of 3-ketosteroids may adversely affect conversion by Δ1-KSTDs. Parti-
cularly, 11β-hydroxy and 11-keto groups have a negative effect on the
activity of the Δ1-KSTDs from Gram-negative bacteria [48].
7.6. Substituents at the C17 position
Δ1-KSTDs accept 3-ketosteroid substrates with varying substituents
at the C17 position. In the crystal structure of Δ1-KSTD1•ADD, the C17
atom of ADD (9) is exposed to solvent. In agreement with this ob-
servation, most characterized Δ1-KSTDs reacted well on 3-ketosteroids
with their C17 carbon atom substituted with hydroxyl (e.g. testosterone;
24), ketone (e.g. AD; 8), acyl (e.g. progesterone; 43), or hydroxyacyl
groups (e.g. cortexolone; 47) [27–29,47–50,52,53]. Δ1-KSTDs from R.
equi [91], N. simplex ATCC 6946 [52], and S. denitrificans Chol-1ST [47]
were even able to 1(2)-dehydrogenate 4-cholesten-3-one (2), and a Δ1-
KSTD from Clostridium paraputrificum was active on 3-oxo-5β-cholan-
24-oic acid (57) [92]. Furthermore, a study on M. tuberculosis H37Rv
[56] implied that its Δ1-KSTD is active on a steroid with a C17 side
chain degradation intermediate. Effects of such substituents on the re-
activity of Δ1-KSTDs toward 3-ketosteroids are variable. For instance,
testosterone was the best tested substrate for the Δ1-KSTDs from R. equi
[29] and N. simplex IFO 12069 [48], but was a somewhat worse sub-
strate for the enzymes from C. testosteroni ATCC 11996 [50] and S.
denitrificans Chol-1ST [47]. Furthermore, the activity of the Δ1-KSTD
from C. testosteroni ATCC 11996 [50] and the Δ1-KSTD2 from R. ery-
thropolis SQ1 [28] on progesterone was, respectively, about 60 and
185% of their activity on AD. Thus, Δ1-KSTDs can generally accept 3-
ketosteroid substrates with diverse substituents at the C17 position, but
with varied, not yet understood, effects on their activity.
8. Inhibition of Δ1-KSTD by steroids
Many dehydrogenases, including alcohol dehydrogenase, isocitrate
dehydrogenase, and β-hydroxysteroid dehydrogenase, can be inhibited
by their own substrate, particularly at elevated substrate concentrations
[112]. This substrate inhibition phenomenon was also observed for the
Δ1-KSTDs from C. testosteroni ATCC 11996 [50] and R. equi [29] when
tested with AD (8) and testosterone (24), respectively, at concentra-
tions over 0.1 mM (Supplementary Table S3). Furthermore, high con-
centrations of AD, cortisol (48), cortisone (53), cortexolone (47) and
progesterone (43) inhibited the activity of N. simplex ATCC 6946 Δ1-
KSTD, with maximal activity at approximately 1 and 0.13mM cortisol
and cortisone, respectively [49,52].
Δ1-KSTD may not only be inhibited by their substrate, but also by
their product. The degree of product inhibition appears to be variable,
however. 1(2)-Dehydrogenation of cortisone, cortexolone, proges-
terone, 19-nor-testosterone (22), and AD by N. simplex ATCC 6946 Δ1-
KSTD was, to some extent, inhibited by their corresponding 1-dehydro
analogs, although the conversion of cortisol was not inhibited [49].
Furthermore, kinetic data on the 1(2)-dehydrogenation of 11β,21-
A. Rohman and B.W. Dijkstra Journal of Steroid Biochemistry and Molecular Biology 191 (2019) 105366
8
dihydroxy-4,17(20)-pregnadiene-3-one (61) and cortisol using Septo-
myxa affinis Δ1-KSTD could only be explained by including product
inhibition [113]. Moreover, the rate of 1(2)-dehydrogenation of AD
with a Δ1-KSTD from C. testosteroni ATCC 11996 was slightly reduced in
the presence of its product ADD (9) [50], but no inhibition was ob-
served with a Δ1-KSTD from B. sphaericus ATCC 7055 at the con-
centration tested [97].
Besides by substrate and product, Δ1-KSTDs may also be inhibited
by other steroids. N. simplex ATCC 6946 Δ1-KSTD was strongly inhibited
non-competitively by dicortinone (60), a steroidal dimer, and by bis-1-
dehydrodicortinone, with Ki values of 0.7 and 0.75 μM, respectively.
This enzyme was also inhibited, but competitively, by 5α-androstane-
3,17-dione (31) and 5α-androstan-17β-ol-3-one (23) with the same Ki
of 25 μM [52]. The activity of S. denitrificans Chol-1ST Δ1-KSTD was
strongly and competitively inhibited by corticosterone (46) and estrone
(39) with Ki values of about 28 and 68 μM, respectively [47]. Likewise,
a Δ1-KSTD from R. rhodochrous IFO 3338 was very sensitive to com-
petitive inhibition by 1-androstene-3,17-dione (17) and estrone (39)
with Ki values of 11 and 26.2 μM, respectively [27]. In contrast, a Δ1-
KSTD from C. testosteroni ATCC 11996 was less sensitive to estrone
[50]. Apparently, inhibition by a steroid is specific to a particular Δ1-
KSTD and, thus, as yet it is not possible to generalize the inhibition of
Δ1-KSTD by steroids.
9. Δ1-KSTD and 1(2)-hydrogenation activity
Although not as widely known as the microbial 1(2)-dehydrogena-
tion of 3-ketosteroids, the reverse reaction, i.e. 1(2)-hydrogenation, has
also been reported for several microorganisms. Fermentation of pre-
dnisone (49) with Streptomyces hydrogenans suggested 4-pregnene-
17α,20β,21-triol-3,11-dione (41) as a possible product [114], in-
dicating that a 1(2)-hydrogenation had taken place. Likewise, N. sim-
plex and Bacterium cyclo-oxydans were reported to reduce both the C-1,2
double bond and the C-20 ketone of triamcinolone (52) [115]. Such
hydrogenation was also reported for baker’s yeast, Saccharomyces cer-
evisiae [116]. The question is whether the 1(2)-dehydrogenation is
catalyzed by a Δ1-KSTD or by another enzyme. In N. simplex VKM Ac-
2033D, 1(2)-dehydrogenation and 1(2)-hydrogenation activities were
reported to be two separable activities [117]. Similarly, a partially
purified steroid 1(2)-hydrogenase from the AD-producing Myco-
bacterium sp. NRRL B-3805 was apparently different from the other
known Δ1-KSTDs and failed to display 1(2)-dehydrogenase activity on
3-ketosteroids [118]. However, by adjusting the medium composition
and aeration rate, 1(2)-dehydrogenation and 1(2)-hydrogenation of 3-
ketosteroids in N. simplex ATCC 6946 and Bacterium cyclo-oxydans
ATCC 12673 [119,120], N. simplex VKM Ac-2033D [121], as well as in
R. erythropolis IMET 7030 and IMET 7185, M. smegmatis IMET SG 99,
and M. phlei IMET SG 1026 [122,123] were shown to be reversible and
performed by seemingly the same enzyme.
An important indication of the in vitro enzymatic 1(2)-hydrogena-
tion of 3-ketosteroids was obtained with a cell-free extract preparation
of a Δ1-KSTD from B. sphaericus ATCC 7055. Incubation of ADD (9) with
a fraction of the cell-free extract in the presence of 3H2O resulted in a
small quantity of highly radioactive AD (8) [66]. Furthermore, a highly
purified Δ1-KSTD from R. erythropolis IMET 7030 was demonstrated to
act both as a 1(2)-dehydrogenase on AD and as a 1(2)-hydrogenase on
ADD in the presence of the electron donor Na2S2O4 [124]. Likewise, a
pure Δ1-KSTD from R. rhodochrous IFO 3338 catalyzed 1(2)-hydro-
genation of ADD using as electron donor Na2S2O4-reduced benzyl vio-
logen under anaerobic conditions [96].
Having both 1(2)-dehydrogenase and 1(2)-hydrogenase capabilities,
the Δ1-KSTD enzymes from R. erythropolis IMET 7030 and R. rhodo-
chrous IFO 3338 were able to catalyze 1(2)-transhydrogenation be-
tween 3-keto-4-ene-steroids and 3-keto-1,4-diene-steroids [83,96]. For
example, in the presence of ADD, 17α-methyltestosterone (26) was
1(2)-dehydrogenated to 1-dehydro-17α-methyltestosterone (27), while
ADD was 1(2)-hydrogenated to AD by the Δ1-KSTD from R. erythropolis
IMET 7030 [83]. Using D2O as the 1(2)-transhydrogenation medium, it
was shown that the enzymes abstract 1α- and 2β-hydrogen atoms from
a 3-keto-4-ene-steroid, transfer the 1α-hydrogen atom to a 3-keto-1,4-
diene-steroid and release the 2β-hydrogen atom to the medium. The
transhydrogenation was reported to be reversible; initially, the catalytic
reaction proceeds rapidly, and, with increasing product concentration,
it decreases until equilibrium is reached [83,96]. Kinetic studies sug-
gested that the transhydrogenation proceeds with a typical ping-pong
mechanism [96].
10. Structure of Δ1-KSTD
10.1. Overall fold
High-resolution crystal structures of Δ1-KSTD are currently avail-
able for the Δ1-KSTD1 isoenzyme from R. erythropolis SQ1 [30]. The Δ1-
KSTD1 molecule has an elongated shape, and consists of two domains,
an FAD-binding domain and a catalytic domain, which are connected
by a two-stranded antiparallel β-sheet. The FAD-binding domain adopts
a Rossmann fold, a characteristic nucleotide-binding fold, with a basic
topology of a symmetrical α/β structure composed of two halves of β1-
α1-β2-α2-β3 and β4-α4-β5-α5-β6 connected at the β3 and β4 strands
by an α-helix (α3) crossover [125,126]. However, some minor mod-
ifications to the basic topology were observed in the FAD-binding do-
main, in which the third β-strand of the second half is missing and the
α-helix crossover is replaced by a three-stranded β-meander. The cat-
alytic domain contains a four-stranded antiparallel β-sheet surrounded
by several α-helices and a small double-stranded antiparallel β-sheet
[30].
The structure of Δ1-KSTD1 is most similar to that of a 3-ketosteroid
Δ4-(5α)-dehydrogenase (Δ4-(5α)-KSTD) from R. jostii RHA1 (PDB 4at0
[127]; 28% sequence identity). The next similar structure is a flavo-
cytochrome c fumarate reductase from Shewanella putrefaciens MR-1
(PDB 1d4c [128]; 24% sequence identity). This is not very surprising
because Δ1-KSTD1 and the two other proteins are all FAD-dependent
enzymes with very similar functions; Δ1-KSTD1 1(2)-dehydrogenates 3-
ketosteroids [30] with a possibility to be reversible (see below), Δ4-
(5α)-KSTD 4(5)-dehydrogenates 3-keto-(5α)-steroids [127], while the
fumarate reductase hydrogenates (reduces) a carbon-carbon double
bond of fumarate [128].
In Δ1-KSTD1, the FAD adopts an extended conformation with an
almost planar isoalloxazine ring system, similar to what has been found
in proteins belonging to the glutathione reductase family [125]. It fits
in an elongated cavity in the FAD-binding domain. Its adenine end is in
front of the parallel β-sheet of the Rossmann fold, while its iso-
alloxazine ring is at the interface of the FAD-binding and catalytic do-
mains. The si-face of the isoalloxazine ring (see Fig. 4) interacts with the
FAD-binding domain, while the re-face is oriented towards the catalytic
domain, and the O4, C4A, N5, and C5A atoms face the bulk solvent
[30].
10.2. Active site
Δ1-KSTD1 possesses a pocket-like active site cavity that is suitable
for binding a steroid ring system. It is located at the interface between
the FAD-binding and the catalytic domains, near the FAD-binding site.
The active site is lined with hydrophobic amino acid residues origi-
nating from both domains and bordered by the re-face of the iso-
alloxazine ring of the FAD prosthetic group [30]. The hydrophobic
nature of the residues that line the active site is conserved among Δ1-
KSTD enzymes (Supplementary Figure S2).
The structure of the Δ1-KSTD1•ADD complex showed that 3-ketos-
teroids are bound by the enzyme via a large number of van der Waals
interactions, a hydrophobic stacking interaction, and two hydrogen
bonds to the C3 carbonyl oxygen atom via the Tyr-487 hydroxyl group
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and the Gly-491 backbone amide. The A-ring of the 3-ketosteroid aligns
almost parallel to the plane of the isoalloxazine ring. It is deeply buried
in the active site and sandwiched between the re-face of the pyrimidine
moiety of the isoalloxazine ring on its α-side and residues Tyr-119 and
Tyr-318 on its β-side. This arrangement places the C1 and C2 atoms of
the 3-ketosteroid at short distances to the N5 atom of the isoalloxazine
ring and the Tyr-318 hydroxyl group, respectively. On the other hand,
the five-membered D-ring of the 3-ketosteroid occupies a solvent-ac-
cessible pocket near the active site entrance [30].
As evidenced by the NCBI protein database, Δ1-KSTD sequences
have been identified in a large number of microbial species. However,
their amino acid sequences are rather similar to the Δ1-KSTD1 sequence
(Supplementary Figure S2). The sequence that was most divergent from
Δ1-KSTD1, was that of a Δ1-KSTD from the Gram-negative bacterium
Achromobacter xylosoxidans (GenPept CKI19020.1), with an identity of
33%. Homology modeling with this latter sequence on the basis of the
Δ1-KSTD1 structure, using the Swiss-Model server [129], produced a
model that showed that the substrate-binding and the FAD-binding
residues are highly conserved. Thus, it can be expected that the ma-
jority of the currently identified Δ1-KSTDs share a similar overall fold
with Δ1-KSTD1.
11. Key residues of Δ1-KSTD
Four active site residues of Δ1-KSTD1 are fully conserved in Δ1-
KSTDs from different species (Supplementary Figure S2). These residues
are Tyr-119, Tyr-487, and Gly-491 from the FAD-binding domain and
Tyr-318 from the catalytic domain. The structure of the Δ1-KSTD1•ADD
complex revealed that the hydroxyl group of Tyr-318 is at reaction
distance to the C2 atom of the 3-ketosteroid ligand, while the hydroxyl
group of Tyr-487 and the backbone amide of Gly-491 make hydrogen
bonds with the C3 carbonyl oxygen atom. Although Tyr-119 has no
close contacts with the bound ADD in the complex structure, its hy-
droxyl group is at hydrogen-bonding distance to the hydroxyl group of
Tyr-318. Their absolute conservation and their interaction with ADD
suggested that the residues are important for activity of Δ1-KSTDs.
Indeed, mutating them confirmed their catalytic importance [30], and
their roles in catalysis were assigned by analogy with the structure and
mechanism of Δ4-(5α)-KSTD [127], an enzyme with a similar 3D
structure to that of Δ1-KSTD1 (see below; [30]).
12. Catalytic mechanism of Δ1-KSTD
A complete catalytic cycle of a flavoenzyme always involves two
half-reactions, i.e. a reductive half-reaction and an oxidative half-re-
action. In the reductive half-reaction the flavin prosthetic group is re-
duced by the substrate, whereas in the oxidative half-reaction the re-
duced prosthetic group is re-oxidized by an electron acceptor [130].
Thus, as discussed above, sustained dehydrogenation by Δ1-KSTDs is
only possible in the presence of an electron acceptor
[27,29,47,50,66,87–91]. At present, the physiological electron acceptor
of the oxidative half-reaction of Δ1-KSTD is unknown, although vitamin
K2(35) [88,89] and molecular oxygen [28,92,102] have been proposed
as possible electron acceptors. Clearly, the details of electron transfer
still need further investigation. On the other hand, a detailed catalytic
mechanism of the reductive half-reaction of Δ1-KSTD, i.e. 3-ketosteroid
1(2)-dehydrogenation, has been described (see below; [30]).
12.1. Dehydration or dehydrogenation?
Enzymatic carbon-carbon double bond formations commonly pro-
ceed either via dehydration (e.g. by fumarase) or via dehydrogenation
(e.g. by acyl coenzyme A dehydrogenase). In the case of dehydration,
the introduction of a double bond into a hydrocarbon moiety, such as at
the C1-C2 position of 3-ketosteroids, would require the introduction of
a hydroxyl group, which is then followed by a dehydration reaction
[81]. However, several observations suggested that this route does not
apply to Δ1-KSTDs. For instance, the Δ1-KSTDs are fully functional in
anaerobic conditions [27,29,47,50,66], while many enzymatic hydro-
xylations require molecular oxygen [131]. Moreover, 1α-, 1β-, and 2α-
hydroxysteroids are not substrates for Δ1-KSTDs [29,50], and 2α-hy-
droxytestosterone is 1(2)-dehydrogenated, instead of dehydrated, by B.
sphaericus ATCC 7055 Δ1-KSTD [132]. Therefore, analogous to other
flavoenzymes, it was already early on postulated that the reaction
catalyzed by Δ1-KSTD most likely proceeds via a direct elimination of
two adjacent hydrogen atoms from its substrate, i.e. dehydrogenation
[29,50].
12.2. Which hydrogen atoms are removed?
The Δ1-KSTD-catalyzed dehydrogenation is generally accepted as
proceeding via a trans-diaxial elimination with removal of the axial α-
hydrogen from the C1 atom and the axial β-hydrogen from the C2 atom
of the 3-ketosteroid substrate [30,52,95–98]. The presence of the α-
hydrogen appeared to be an absolute requirement for reactivity. 1α-
Substituted 3-ketosteroids were not 1(2)-dehydrogenated by Δ1-KSTDs,
but 1β-substituted analogs gave excellent 1(2)-dehydrogenation pro-
ducts under the same conditions [52,95,98]. Accordingly, experiments
using deuterium-labeled substrates indicated that all hydrogen atoms
released from the C1 atom during 1(2)-dehydrogenation by Δ1-KSTDs
originated specifically from the α-position [96,98]. Furthermore, in Δ1-
KSTD-catalyzed 1(2)-transhydrogenations, the 1α-hydrogen of a 3-keto-
4-ene-steroid was transferred directly to a 3-keto-1,4-diene-steroid that
served as the electron acceptor [83,96]. On the other hand, the pre-
sence of the 2β-hydrogen is not obligatory. B. sphaericus ATCC 7055 Δ1-
KSTD completely 1(2)-dehydrogenated not only 2α-substituted 3-ke-
tosteroids, but also 2β-hydroxy-3-ketosteroids, albeit with a poorer
conversion yield [95,98]. Furthermore, the enzyme 1(2)-dehy-
drogenated 2β-deutero-5α-androstane-3,17-dione (cf. 31) with only
86% rather than 100% depletion of the deuterium [97,98], also in-
dicating that the enzyme is not fully specific for removal of the 2β-
hydrogen atom. This lack of specificity could be due to the formation of
a transient reactive species that may undergo fast exchange of the C2
hydrogen with solvent [83,96–98]. Apart from Δ1-KSTD, the trans-
diaxial dehydrogenation mechanism was also observed for Δ4-(5α)-
KSTD [127]. Such a mechanism is highly similar to that of acyl coen-
zyme A dehydrogenases [133,134].
12.3. Are the hydrogens removed simultaneously or one by one?
Δ1-KSTDs can catalyze the exchange of alkali-labile tritium or
deuterium atoms at the C2 atom of their substrates, even when enzyme
turnover was prevented by the absence of an electron acceptor for the
oxidative half-reaction [97,98] or by keeping the flavin prosthetic
group in the reduced state [96]. This observation indicates that the
enzymes more likely employ a stepwise unimolecular elimination
conjugate base (E1cB) mechanism, in which departure of the first hy-
drogen atom precedes that of the second hydrogen atom. Such a me-
chanism requires the formation of an intermediate. A concerted bimo-
lecular elimination (E2) mechanism, in which the two hydrogens depart
simultaneously without the formation of an intermediate, is less likely.
Thus, 1(2)-dehydrogenation by Δ1-KSTD has been considered to involve
a two-step mechanism, i.e. an initial fast step followed by a slow rate-
determining step [98]. The fast step was proposed to be initiated by an
interaction of the C3 carbonyl group of the 3-ketosteroid substrate with
an electrophile. This interaction stimulates labilization of the C2 hy-
drogen atoms. Subsequent abstraction of a proton from this atom by a
general base results in either an enolate [97,98] or a carbanionic [96]
intermediate. In the slow step, a double bond is proposed to be formed
between the C1 and C2 atoms when a hydride ion is transferred from
the C1 atom of the intermediate to the flavin prosthetic group [96–98].
This proposed step-wise mechanism is in contrast to the concerted
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removal of the hydrogens catalyzed by acyl coenzyme A dehy-
drogenases [133,134].
12.4. Information from the crystal structure of Δ1-KSTD
The nature and positions of the amino-acid residues involved in
catalysis by Δ1-KSTD were clarified with the structure determination of
the Δ1-KSTD1•ADD complex combined with mutational studies on the
enzyme. A superposition of the structure of the substrate AD (8) on that
of the product ADD (9) as bound in the Δ1-KSTD1•ADD complex
structure revealed that 1) the hydroxyl group of Tyr-487 and the
backbone amide of Gly-491 would be at the right positions for hydrogen
bond formation with the C3 carbonyl group of the substrate; 2) the
hydroxyl group of Tyr-318 would be at ˜3.0 Å from the C2 atom of the
substrate; 3) the N5 atom of the FAD isoalloxazine ring would be at ˜2.6
Å from the C1 atom of the substrate; and 4) the isoalloxazine ring and
Tyr-318 would be on opposite sides of the A-ring of the substrate, with
the isoalloxazine ring at the α-side and Tyr-318 at the β-side. Thus, the
substrate would be bound in the active site such that its C1 and C2
atoms are positioned appropriately for hydride and proton abstraction,
respectively [30].
These observations facilitated a detailed description of the 1(2)-
dehydrogenation mechanism of Δ1-KSTD1 (Fig. 4) [30]. Tyr-487 and
Gly-491 tightly bind the carbonyl oxygen of the 3-ketosteroid substrate
to promote keto-enol tautomerization and labilization of the C2 hy-
drogen atoms. The hydroxyl group of Tyr-318 serves as a general base
that abstracts the axial β-hydrogen from the C2 atom as a proton. A
transient carbanionic intermediate, which is most likely stabilized by
keto-enol tautomerization, is formed. This negatively charged inter-
mediate can be stabilized by the delocalization of its charge over the C3
keto group and the interaction with the positive N-terminal helix
macro-dipole of a nearby α-helix. Tyr-119, whose hydroxyl group is
hydrogen bonded to the Tyr-318 hydroxyl group, may increase the
basic character of Tyr-318 and facilitate proton relay to the solvent. The
negative charge of the intermediate is then shifted to the C1 atom to
form the double bond between the C1 and C2 atoms. In synchrony, the
N5 atom of the FAD prosthetic group abstracts the axial α-hydrogen
from the C1 atom as a hydride ion, generating a reduced anionic FAD.
The negative charge of this anion can be delocalized over the pyr-
imidine moiety of the isoalloxazine prosthetic group. The pyrimidine
moiety is stabilized by hydrogen bonding interactions with the protein
backbone as well as by the helix macro-dipole interaction with the N-
terminal end of an α-helix. Re-oxidation of the reduced FAD by an
electron acceptor in the subsequent oxidative half-reaction will com-
plete the catalytic cycle and make the enzyme available for another
cycle [30].
13. Concluding remarks
A crucial step in the microbial degradation of steroids is the 1(2)-
dehydrogenation of the steroid nucleus by FAD-dependent Δ1-KSTDs.
This step is required to initiate the opening of the steroid nucleus under
both aerobic and anaerobic conditions. A large variety of steroid-de-
grading microorganisms can carry out this biotransformation or harbor
gene(s) encoding (putative) Δ1-KSTD(s), attesting the enzyme’s phy-
siological importance and role. Many microorganisms, particularly
from the phylum Actinobacteria, may even express multiple Δ1-KSTD
isoenzymes. In line with their widespread distribution, Δ1-KSTDs have
quite diverse amino acid sequences. Yet, even the most deviating se-
quences appear to be compatible with the R. erythropolis SQ1 Δ1-KSTD1
fold, suggesting that Δ1-KSTDs share a common overall fold.
Biochemical, structural, and mutational studies substantiated that Δ1-
KSTDs catalyze a direct 1(2)-dehydrogenation of 3-ketosteroid sub-
strates. The enzymes make use of a Tyr residue to abstract the axial β-
hydrogen from the C2 atom of the substrate as a proton and use FAD to
accept the axial α-hydrogen from the C1 atom as a hydride ion. To
complete the catalytic cycle, the reduced FAD should be re-oxidized by
an electron acceptor. However, the nature of the electron acceptor and
mechanism of the re-oxidation are currently incompletely understood
and need further investigation. Finally, although AD is a common
substrate for Δ1-KSTDs, most biochemically-characterized enzymes are
able to accept a wide range of naturally occurring and chemically
modified 3-ketosteroids as substrates. How the Δ1-KSTDs fine-tune their
substrate specificity is an intriguing subject for further investigation,
which may be of interest for future biotechnological development and
production of specialty steroids.
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